Barinthus Biotherapeutics plc.
BRNSDelisted Sep 9, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828185
Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Barinthus Biotherapeutics plc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q4 2024
- Shares held
- 9.49M
- −231.8K (−2.4%) vs. Q4 2024
- Total value
- $9.15M
- −$1.19M (−11.5%) vs. Q4 2024
- New holders
- 3
- 2 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $7.84M |
| Q1 2026 | 14 | $7.89M |
| Q4 2025 | 13 | $6.10M |
| Q3 2025 | 15 | $10.4M |
| Q2 2025 | 14 | $9.02M |
| Q1 2025 | 15 | $9.15M |
| Q4 2024 | 16 | $10.3M |
| Q3 2024 | 19 | $10.7M |
| Q2 2024 | 18 | $11.8M |
| Q1 2024 | 15 | $21.3M |
| Q4 2023 | 15 | $36.5M |
| Q3 2023 | 16 | $29.5M |
| Q2 2023 | 15 | $20.0M |
| Q1 2023 | 13 | $21.6M |
| Q4 2022 | 15 | $22.2M |
| Q3 2022 | 11 | $31.2M |
| Q2 2022 | 13 | $27.5M |
| Q1 2022 | 12 | $23.8M |
| Q4 2021 | 15 | $54.3M |
| Q3 2021 | 15 | $77.6M |
| Q2 2021 | 19 | $76.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Barinthus Biotherapeutics plc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| M&G Plc | 5,197,349 | $5.20M | 0.02% | 00.0% | Unchanged |
| Alphabet Inc. | 1,513,644 | $1.47M | 0.09% | 00.0% | Unchanged |
| SC China Holding Ltd | 1,420,473 | $1.16M | 0.07% | 00.0% | Unchanged |
| DC Funds, LP | 642,204 | $624.7K | 30.22% | 00.0% | Unchanged |
| Gilead Sciences, Inc. | 369,855 | $359.8K | 0.03% | −250,496−40.4% | Reduced |
| Johns Hopkins University | 122,237 | $118.9K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 92,461 | $89.9K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 37,450 | $36.4K | 0.00% | +37,450 | New |
| Renaissance Technologies LLC | 35,700 | $34.7K | 0.00% | +600+1.7% | Added |
| Citadel Advisors LLC | 26,172 | $25.9K | 0.00% | +26,172 | New |
| Janney Montgomery Scott LLC | 15,373 | $15.0K | 0.00% | +365+2.4% | Added |
| Geode Capital Management, LLC | 11,568 | $11.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 871 | $847 | 0.00% | −7,150−89.1% | Reduced |
| New England Capital Financial Advisors LLC | 45 | $44 | 0.00% | −59−56.7% | Reduced |
| Royal Bank of Canada | 105 | $0 | 0.00% | +105 | New |
| Ipswich Investment Management Co., Inc. | 0 | $0 | 0.00% | −17,575−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,960−100.0% | Sold out |
| Catalina Capital Group, LLC | 0 | $0 | 0.00% | −10,216−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −60−100.0% | Sold out |